ScreenerHero

CHEMM ChemoMetec A/S

CPH · DK · Healthcare · Medical Devices · chemometec.com
585.00DKK+6.27%Mkt Cap: 1.46B $P/E: 50.43

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$174.36BUSDP/E 32.3
MDT
Medtronic plc
$112.53BUSDP/E 21.6
SYK
Stryker Corporation
$109.40BUSDP/E 29.6
BSX
Boston Scientific Corporation
$61.45BUSDP/E 17.2
EW
Edwards Lifesciences Corporation
$50.23BUSDP/E 51.9
SHL
Siemens Healthineers AG
$46.06BUSDP/E 19.2
DXCM
DexCom, Inc.
$32.79BUSDP/E 34.5
GEHC
GE HealthCare Technologies Inc.
$29.90BUSDP/E 15.1
PHG
Koninklijke Philips N.V.
$23.37BUSDP/E 17.8
PHIA
Koninklijke Philips N.V.
$22.58BUSDP/E 18.5
STE
STERIS plc
$20.58BUSDP/E 25.8
SOON
Sonova Holding AG
$17.06BUSDP/E 27.9
ZBH
Zimmer Biomet Holdings, Inc.
$17.47BUSDP/E 22.2
TXG
10x Genomics, Inc.
$12.73BUSD
PEN
Penumbra, Inc.
$12.49BUSDP/E 77.9
SNN
Smith & Nephew plc
$11.27BUSDP/E 18.3
GMED
Globus Medical, Inc.
$10.28BUSDP/E 19.6
BIO
Bio-Rad Laboratories, Inc.
$10.16BUSDP/E 48.1
DEMANT
Demant A/S
$9.81BUSDP/E 27.8
BRKR
Bruker Corporation
$9.73BUSD

Key Statistics

Company
Market Cap1.46B USD
Enterprise Value1.34B USD
Revenue (TTM)74.44M USD
Gross Profit70.79M USD
Net Income (TTM)29.40M USD
Revenue/Share29.37 DKK
Last Price585.00 DKK
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees174
CountryDK
SectorHealthcare
IndustryMedical Devices
ISINDK0060055861
Valuation
P/E (Trailing)50.43
P/E (Forward)33.78
PEG—
EV/EBITDA34.53
EV/Revenue17.96
P/S18.49
P/B13.13
EPS (TTM)11.60
EPS (Forward)16.30
52W Range
235.2061% of range804.00
52W High804.00 DKK
52W Low235.20 DKK
Profitability
Gross Margin95.10%
Oper. Margin49.77%
EBITDA Margin52.02%
Profit Margin39.49%
ROE27.82%
ROA23.44%
Growth
Revenue Growth7.40%
Earnings Growth51.30%
Cash Flow & Leverage
Operating CF30.64M USD
CapEx (TTM)14.04M USD
FCF Margin11.22%
FCF Yield0.57%
Net Debt-42.09M USD
Net Debt/EBITDA-1.09
Balance Sheet
Debt/Equity0.01
Current Ratio4.09
Quick Ratio3.06
Book Value/Sh41.94 DKK
Cash/Share17.07 DKK
Dividends
Fwd Div Rate7.00 DKK
Trail. Div Rate0.00 DKK
Div. Yield1.27%
5Y Avg Yield—
Payout Ratio60.34%
Ex-Div DateOct 10, 2025
Pay Date—
Analyst Consensus
Rating—
Target (Mean)635.00 DKK
Upside (mean)+8.5%
Target Range550.00 DKK – 715.00 DKK
550.00+8.5% to mean715.00
# Analysts3
Ownership
Shares Out.17.16M
Float16.48M
Insiders3.73%
Institutions54.02%
Technical
SMA 50484.19 (+20.8%)
SMA 200443.77 (+31.8%)
Beta1.39
S&P 52W Chg14.58%
Avg Vol (30d)74.69K
Avg Vol (10d)50.57K
Technical Indicators
RSI (14)73.2
MACD17.5640
MACD Signal14.1580
MACD Hist.+3.4060
BB Upper561.20 DKK
BB Middle518.66 DKK
BB Lower476.12 DKK
BB Width16.40%
ATR (14)22.47 DKK
Vol Ratio (20d)2.21x